P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib
Title:
P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib
Author:
Bartsch, R. Harbeck, N. Wrobel, D. Zaiss, M. Terhaag, J. Guth, D. Distelrath, A. Wuerstlein, R. Zahn, M.-O. Lüftner, D. Schwitter, M. Balic, M. Jackisch, C. Müller, V. Rinnerthaler, G. Schmidt, M. Zaman, K. Schinköthe, T. Gorray, M. Breitenstein, U.